Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Epigenetic silencing of CYP24 in tumor-derived endothelial cells contributes to selective growth inhibition by calcitriol.

Chung I, Karpf AR, Muindi JR, Conroy JM, Nowak NJ, Johnson CS, Trump DL.

J Biol Chem. 2007 Mar 23;282(12):8704-14. Epub 2007 Jan 22.

2.

Epigenetic silencing of CYP24 in the tumor microenvironment.

Johnson CS, Chung I, Trump DL.

J Steroid Biochem Mol Biol. 2010 Jul;121(1-2):338-42. doi: 10.1016/j.jsbmb.2010.03.046. Epub 2010 Mar 19.

3.

Anti-proliferative effects of calcitriol on endothelial cells derived from two different microenvironments.

Chung I, Yu WD, Karpf AR, Flynn G, Bernardi RJ, Modzelewski RA, Johnson CS, Trump DL.

J Steroid Biochem Mol Biol. 2007 Mar;103(3-5):768-70. Review.

PMID:
17368191
4.

Calcitriol (1,25-dihydroxycholecalciferol) selectively inhibits proliferation of freshly isolated tumor-derived endothelial cells and induces apoptosis.

Flynn G, Chung I, Yu WD, Romano M, Modzelewski RA, Johnson CS, Trump DL.

Oncology. 2006;70(6):447-57. Epub 2007 Jan 19.

PMID:
17237620
5.

Differential antiproliferative effects of calcitriol on tumor-derived and matrigel-derived endothelial cells.

Chung I, Wong MK, Flynn G, Yu WD, Johnson CS, Trump DL.

Cancer Res. 2006 Sep 1;66(17):8565-73.

6.

Role of vitamin D receptor in the antiproliferative effects of calcitriol in tumor-derived endothelial cells and tumor angiogenesis in vivo.

Chung I, Han G, Seshadri M, Gillard BM, Yu WD, Foster BA, Trump DL, Johnson CS.

Cancer Res. 2009 Feb 1;69(3):967-75. doi: 10.1158/0008-5472.CAN-08-2307. Epub 2009 Jan 13.

8.

DNA methylation-related vitamin D receptor insensitivity in breast cancer.

Marik R, Fackler M, Gabrielson E, Zeiger MA, Sukumar S, Stearns V, Umbricht CB.

Cancer Biol Ther. 2010 Jul 1;10(1):44-53. Epub 2010 Jul 9.

9.

Effects of MAPK signaling on 1,25-dihydroxyvitamin D-mediated CYP24 gene expression in the enterocyte-like cell line, Caco-2.

Cui M, Zhao Y, Hance KW, Shao A, Wood RJ, Fleet JC.

J Cell Physiol. 2009 Apr;219(1):132-42. doi: 10.1002/jcp.21657.

10.

The effect of differentiation on 1,25 dihydroxyvitamin D-mediated gene expression in the enterocyte-like cell line, Caco-2.

Cui M, Klopot A, Jiang Y, Fleet JC.

J Cell Physiol. 2009 Jan;218(1):113-21. doi: 10.1002/jcp.21574.

11.

Extensive methylation of CpG island of CYP24 gene in osteoblastic ROS17/2.8 cells.

Ohyama Y, Kusada T, Yamasaki T, Ide H.

Nucleic Acids Res Suppl. 2002;(2):249-50.

12.

Epigenetic regulation of vitamin D 24-hydroxylase/CYP24A1 in human prostate cancer.

Luo W, Karpf AR, Deeb KK, Muindi JR, Morrison CD, Johnson CS, Trump DL.

Cancer Res. 2010 Jul 15;70(14):5953-62. doi: 10.1158/0008-5472.CAN-10-0617. Epub 2010 Jun 29.

13.

Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.

Yuan J, Luo RZ, Fujii S, Wang L, Hu W, Andreeff M, Pan Y, Kadota M, Oshimura M, Sahin AA, Issa JP, Bast RC Jr, Yu Y.

Cancer Res. 2003 Jul 15;63(14):4174-80.

14.

Epigenetic regulation of vitamin D hydroxylase expression and activity in normal and malignant human prostate cells.

Khorchide M, Lechner D, Cross HS.

J Steroid Biochem Mol Biol. 2005 Feb;93(2-5):167-72. Epub 2005 Feb 5.

PMID:
15860259
15.

Steroid and xenobiotic receptor and vitamin D receptor crosstalk mediates CYP24 expression and drug-induced osteomalacia.

Zhou C, Assem M, Tay JC, Watkins PB, Blumberg B, Schuetz EG, Thummel KE.

J Clin Invest. 2006 Jun;116(6):1703-12. Epub 2006 May 11.

16.

The number of vitamin D receptor binding sites defines the different vitamin D responsiveness of the CYP24 gene in malignant and normal mammary cells.

Matilainen JM, Malinen M, Turunen MM, Carlberg C, Väisänen S.

J Biol Chem. 2010 Jul 30;285(31):24174-83. doi: 10.1074/jbc.M110.124073. Epub 2010 May 11.

17.

Epigenetic and HIF-1 regulation of stanniocalcin-2 expression in human cancer cells.

Law AY, Lai KP, Ip CK, Wong AS, Wagner GF, Wong CK.

Exp Cell Res. 2008 May 1;314(8):1823-30. doi: 10.1016/j.yexcr.2008.03.001. Epub 2008 Mar 8.

PMID:
18394600
18.

Gene silencing of EREG mediated by DNA methylation and histone modification in human gastric cancers.

Yun J, Song SH, Park J, Kim HP, Yoon YK, Lee KH, Han SW, Oh DY, Im SA, Bang YJ, Kim TY.

Lab Invest. 2012 Jul;92(7):1033-44. doi: 10.1038/labinvest.2012.61. Epub 2012 Apr 16. Erratum in: Lab Invest. 2013 Oct;93(10):1165.

19.

Using chromatin immunoprecipitation to monitor 1alpha,25-dihydroxyvitamin D3-dependent chromatin activity on the human CYP24 promoter.

Väisänen S, Dunlop TW, Frank C, Carlberg C.

J Steroid Biochem Mol Biol. 2004 May;89-90(1-5):277-9.

PMID:
15225785
20.

Spatio-temporal activation of chromatin on the human CYP24 gene promoter in the presence of 1alpha,25-Dihydroxyvitamin D3.

Väisänen S, Dunlop TW, Sinkkonen L, Frank C, Carlberg C.

J Mol Biol. 2005 Jul 1;350(1):65-77.

PMID:
15919092
Items per page

Supplemental Content

Write to the Help Desk